---
title: "Jolly: In 2024, the net profit attributable to the parent company is expected to increase by 32.60% year-on-year, and it plans to distribute a dividend of 6 yuan for every 10 shares"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/237378725.md"
description: "36Kr learned that Jolly released its annual report for 2024. The report shows that in 2024, the company achieved operating revenue of 2.578 billion yuan, a year-on-year increase of 32.71%; the net profit attributable to shareholders of the listed company was 508 million yuan, a year-on-year increase of 32.60%; and the basic earnings per share was 0.73 yuan. The company plans to distribute a cash dividend of 6 yuan (including tax) for every 10 shares to all shareholders"
datetime: "2025-04-24T12:12:45.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/237378725.md)
  - [en](https://longbridge.com/en/news/237378725.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/237378725.md)
---

# Jolly: In 2024, the net profit attributable to the parent company is expected to increase by 32.60% year-on-year, and it plans to distribute a dividend of 6 yuan for every 10 shares

36Kr learned that Jolly released its annual report for 2024. The report shows that in 2024, the company achieved operating revenue of 2.578 billion yuan, a year-on-year increase of 32.71%; the net profit attributable to shareholders of the listed company was 508 million yuan, a year-on-year increase of 32.60%; and the basic earnings per share were 0.73 yuan. The company plans to distribute a cash dividend of 6 yuan (including tax) for every 10 shares to all shareholders

### Related Stocks

- [300181.CN](https://longbridge.com/en/quote/300181.CN.md)

## Related News & Research

- [Baidu: AI Cloud Infra and GPU cloud drove growth and margin gains despite overall revenue decline](https://longbridge.com/en/news/296242242.md)
- [Demant hearing care chief Niels Wagner sells shares worth DKK 1.47 million](https://longbridge.com/en/news/296345010.md)
- [Baidu: AI-powered business growth offset revenue decline, with strong cash flow and global expansion](https://longbridge.com/en/news/296208127.md)
- [Baidu says Wenxin will return to AI’s top tier, targets Hong Kong listing by year-end](https://longbridge.com/en/news/296308374.md)
- [CSPC Innovation Pharmaceutical: Biopharma licensing and product launches drove record revenue and profit growth](https://longbridge.com/en/news/296129143.md)